BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
18 results:

  • 1. Superficial dedifferentiated liposarcoma: A clinicopathologic study.
    Bourgeau M; Gandhi JS; Deeb KK; Bahrami A
    Hum Pathol; 2024 Mar; 145():63-70. PubMed ID: 38423223
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
    Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
    Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
    Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
    J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circ_0002770, acting as a competitive endogenous RNA, promotes proliferation and invasion by targeting miR-331-3p in melanoma.
    Qian P; Linbo L; Xiaomei Z; Hui P
    Cell Death Dis; 2020 Apr; 11(4):264. PubMed ID: 32327630
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and mdm2 as a potential therapy in uveal melanoma.
    Decaudin D; Frisch Dit Leitz E; Nemati F; Tarin M; Naguez A; Zerara M; Marande B; Vivet-Noguer R; Halilovic E; Fabre C; Jochemsen A; Roman-Roman S; Alsafadi S
    Eur J Cancer; 2020 Feb; 126():93-103. PubMed ID: 31927215
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.
    Fujiyama H; Tsuji T; Hironaka K; Yoshida K; Sugimoto N; Fujita M
    J Biochem; 2020 Jan; 167(1):15-24. PubMed ID: 31545368
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; de Moraes AM; Lima CS
    Med Oncol; 2017 Feb; 34(2):19. PubMed ID: 28050764
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma.
    Weissinger SE; Keil P; Silvers DN; Klaus BM; Möller P; Horst BA; Lennerz JK
    Mod Pathol; 2014 Apr; 27(4):524-34. PubMed ID: 24051699
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular pathology of uveal melanoma.
    Coupland SE; Lake SL; Zeschnigk M; Damato BE
    Eye (Lond); 2013 Feb; 27(2):230-42. PubMed ID: 23222563
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma.
    Higaki-Mori H; Kuwamoto S; Iwasaki T; Kato M; Murakami I; Nagata K; Sano H; Horie Y; Yoshida Y; Yamamoto O; Adachi K; Nanba E; Hayashi K
    Hum Pathol; 2012 Dec; 43(12):2282-91. PubMed ID: 22795182
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.
    de Lange J; Ly LV; Lodder K; Verlaan-de Vries M; Teunisse AF; Jager MJ; Jochemsen AG
    Oncogene; 2012 Mar; 31(9):1105-16. PubMed ID: 21765463
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [p53 gene expression and activation of p53-dependent transcription in melanoma cell lines].
    Mol Biol (Mosk); 2005; 39(3):445-56. PubMed ID: 15981574
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. hdm2 protein overexpression and prognosis in primary malignant melanoma.
    Polsky D; Melzer K; Hazan C; Panageas KS; Busam K; Drobnjak M; Kamino H; Spira JG; Kopf AW; Houghton A; Cordon-Cardo C; Osman I
    J Natl Cancer Inst; 2002 Dec; 94(23):1803-6. PubMed ID: 12464652
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of the novel role of pRB in eye cancer.
    Lai H; Ma F; Lai S
    J Cell Biochem; 2003 Jan; 88(1):121-7. PubMed ID: 12461781
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic value of cyclin D1, p53, and mdm2 protein expression in uveal melanoma.
    Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
    J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of biomarkers in malignant melanoma.
    Hernberg M; Turunen JP; von Boguslawsky K; Muhonen T; Pyrhönen S
    Melanoma Res; 1998 Jun; 8(3):283-91. PubMed ID: 9664152
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.